The Hedgeweek Interview: Kevin Pilarski, partner and derivative portfolio manager, Kilkenny Capital Management: Focusing on opportunities in the biomedical sector
Kevin Pilarski outlines the investment process and analysis that underlies the performance of Kilkenny’s biomedical-focused range of funds.